US5639724A
(en)
*
|
1984-07-24 |
1997-06-17 |
Sandoz Ltd. |
Cyclosporin galenic forms
|
GB2222770B
(en)
*
|
1988-09-16 |
1992-07-29 |
Sandoz Ltd |
Pharmaceutical compositions containing cyclosporins
|
US6007840A
(en)
*
|
1988-09-16 |
1999-12-28 |
Novartis Ag |
Pharmaceutical compositions comprising cyclosporins
|
GR1000466B
(el)
*
|
1989-01-28 |
1992-07-30 |
Sandoz Ag |
Μεθοδος παρασκευης νεων φαρμακευτικων μορφων κυκλοσπορινης.
|
CH679277A5
(ko)
*
|
1989-02-09 |
1992-01-31 |
Sandoz Ag |
|
US7081445B2
(en)
*
|
1989-02-20 |
2006-07-25 |
Novartis Ag |
Cyclosporin galenic forms
|
US4996193A
(en)
*
|
1989-03-03 |
1991-02-26 |
The Regents Of The University Of California |
Combined topical and systemic method of administration of cyclosporine
|
GB8916901D0
(en)
|
1989-07-24 |
1989-09-06 |
Sandoz Ltd |
Improvements in or relating to organic compounds
|
HU208491B
(en)
*
|
1990-11-27 |
1993-11-29 |
Gyogyszerkutato Intezet |
Process for producing oral pharmaceutical composition containing cyclosporin
|
ATE183099T1
(de)
*
|
1991-04-19 |
1999-08-15 |
Lds Technologies Inc |
Konvertierbare mikroemulsionsverbindungen
|
US6262022B1
(en)
|
1992-06-25 |
2001-07-17 |
Novartis Ag |
Pharmaceutical compositions containing cyclosporin as the active agent
|
AU688920B2
(en)
*
|
1991-06-27 |
1998-03-19 |
Novartis Ag |
Transesterified corn oil products
|
GB9113872D0
(en)
*
|
1991-06-27 |
1991-08-14 |
Sandoz Ag |
Improvements in or relating to organic compounds
|
IL102236A0
(en)
*
|
1991-06-27 |
1993-01-14 |
Ltt Inst Co Ltd |
Topical preparations containing cyclosporin
|
GB9208712D0
(en)
*
|
1992-04-22 |
1992-06-10 |
Sandoz Ltd |
Pharmaceutical compositions containing cyclosporin derivates
|
DK0642332T3
(da)
*
|
1992-05-13 |
1997-06-16 |
Sandoz Ltd |
Ophthalmiske præparater indeholdende cyclosporin
|
DK0589843T3
(da)
*
|
1992-09-25 |
2002-04-02 |
Novartis Ag |
Cyclosporinholdige farmaceutiske præparater
|
HUT72738A
(en)
†
|
1993-04-20 |
1996-05-28 |
Rentschler Arzneimittel |
New cyclosporine-containing pharmaceutical compositions for oral administration
|
NZ247516A
(en)
*
|
1993-04-28 |
1995-02-24 |
Bernard Charles Sherman |
Water dispersible pharmaceutical compositions comprising drug dissolved in solvent system comprising at least one alcohol and at least one surfactant
|
DE4447972B4
(de)
*
|
1993-05-27 |
2007-12-27 |
Novartis Ag |
Galenische Formulierungen
|
CH686761A5
(de)
*
|
1993-05-27 |
1996-06-28 |
Sandoz Ag |
Galenische Formulierungen.
|
AT408520B
(de)
*
|
1993-05-27 |
2001-12-27 |
Novartis Erfind Verwalt Gmbh |
Galenische formulierungen
|
GB2278780B
(en)
*
|
1993-05-27 |
1998-10-14 |
Sandoz Ltd |
Macrolide formulations
|
DE4322826A1
(de)
*
|
1993-07-08 |
1995-01-12 |
Galenik Labor Freiburg Gmbh |
Pharmazeutisches Präparat
|
GB2281697A
(en)
*
|
1993-09-14 |
1995-03-15 |
Euro Celtique Sa |
Laxative compositions in capsules
|
ATE398448T1
(de)
*
|
1993-09-28 |
2008-07-15 |
Scherer Gmbh R P |
Herstellung von weichgelatinekapseln
|
GB2315216B
(en)
*
|
1993-10-05 |
1998-10-14 |
Ciba Geigy Ag |
Microemulsion preconcentrates comprising FK506 or 33-epi-chloro-33-desoxy-ascomycin
|
DE4340781C3
(de)
*
|
1993-11-30 |
2000-01-27 |
Novartis Ag |
Cyclosporin enthaltende flüssige Zubereitungen und Verfahren zu ihrer Herstellung
|
KR0146671B1
(ko)
*
|
1994-02-25 |
1998-08-17 |
김충환 |
사이클로스포린-함유 분말 조성물
|
GB9405304D0
(en)
*
|
1994-03-16 |
1994-04-27 |
Scherer Ltd R P |
Delivery systems for hydrophobic drugs
|
US5447729A
(en)
*
|
1994-04-07 |
1995-09-05 |
Pharmavene, Inc. |
Multilamellar drug delivery systems
|
US5474979A
(en)
*
|
1994-05-17 |
1995-12-12 |
Allergan, Inc. |
Nonirritating emulsions for sensitive tissue
|
FI100692B
(fi)
*
|
1994-05-24 |
1998-02-13 |
Leiras Oy |
Menetelmä farmaseuttisten koostumusten valmistamiseksi, jolloin koostu mukset pohjautuvat mikroemulsiogeeleihin sekä uusia mikroemulsioihin p ohjautuvia geelejä
|
IL115742A
(en)
*
|
1994-10-26 |
2000-06-01 |
Novartis Ag |
Pharmaceutical compositions comprising a difficultly soluble active agent a hydrophilic phase a lipophilic phase and a surfactant
|
GB2308545B
(en)
*
|
1994-10-26 |
1999-06-02 |
Novartis Ag |
Pharmaceutical microemulsion preconcentrates
|
BR9509550A
(pt)
|
1994-11-03 |
1997-09-16 |
Dresden Arzneimittel |
Formulações de ciclosporina para administração oral com composição simples e alta biodisponibilidade e processo para sua produção
|
US5603951A
(en)
*
|
1994-11-09 |
1997-02-18 |
Hanmi Pharm. Ind. Co., Ltd. |
Cyclosporin-containing soft capsule compositions
|
HU215966B
(hu)
*
|
1994-11-21 |
1999-07-28 |
BIOGAL Gyógyszergyár Rt. |
Orálisan alkalmazható, ciklosporint tartalmazó, összetett emulzió-előkoncentrátum
|
KR0167613B1
(ko)
*
|
1994-12-28 |
1999-01-15 |
한스 루돌프 하우스, 니콜 케르커 |
사이클로스포린-함유 연질캅셀제 조성물
|
WO1996036316A1
(en)
*
|
1995-05-19 |
1996-11-21 |
Abbott Laboratories |
Self-emulsifying formulations of lipophilic drugs
|
US6696413B2
(en)
*
|
1995-06-16 |
2004-02-24 |
Hexal Ag |
Pharmaceutical preparation with cyclosporin A
|
EP0760237A1
(en)
*
|
1995-08-30 |
1997-03-05 |
Cipla Limited |
Oil-in-water microemulsions
|
DE19544507B4
(de)
|
1995-11-29 |
2007-11-15 |
Novartis Ag |
Cyclosporin enthaltende Präparate
|
NZ280689A
(en)
*
|
1995-12-15 |
1997-08-22 |
Bernard Charles Sherma Sherman |
Pharmaceutical composition comprising a cyclosporipharmaceutical composition comprising a cyclosporin; a tocol, tocopherol or tocotrienol; and propylen; a tocol, tocopherol or tocotrienol; and propylene carbonate or polyethylene glycol ne carbonate or polyethylene glycol
|
CZ288631B6
(cs)
*
|
1996-01-18 |
2001-08-15 |
Galena, A. S. |
Léčivé přípravky s obsahem cyklosporinu
|
GB9601120D0
(en)
*
|
1996-01-19 |
1996-03-20 |
Sandoz Ltd |
Organic compounds
|
US5858401A
(en)
*
|
1996-01-22 |
1999-01-12 |
Sidmak Laboratories, Inc. |
Pharmaceutical composition for cyclosporines
|
US6245349B1
(en)
*
|
1996-02-23 |
2001-06-12 |
éLAN CORPORATION PLC |
Drug delivery compositions suitable for intravenous injection
|
KR970064620A
(ko)
*
|
1996-03-05 |
1997-10-13 |
임성기 |
사이클로스포린-함유 외용약제 조성물
|
SE511313C2
(sv)
|
1997-01-13 |
1999-09-06 |
Gs Dev Ab |
Komposition med reglerad frisättning innefattande fettsyraester av diacylglycerol
|
KR20050084502A
(ko)
*
|
1997-01-30 |
2005-08-26 |
노파르티스 아게 |
오일을 함유하지 않은 사이클로스포린 a 함유 제약 조성물
|
US6426078B1
(en)
|
1997-03-17 |
2002-07-30 |
Roche Vitamins Inc. |
Oil in water microemulsion
|
HU228923B1
(en)
|
1997-07-29 |
2013-06-28 |
Upjohn Co |
Pharmaceutical composition for acidic lipophilic compounds in a form of a self-emulsifying formulation
|
US6531139B1
(en)
|
1997-07-29 |
2003-03-11 |
Pharmacia & Upjohn Company |
Self-emulsifying formulation for lipophilic compounds
|
US6346511B1
(en)
|
1997-09-08 |
2002-02-12 |
Panacea Biotec Limited |
Pharmaceutical composition comprising cyclosporin
|
US6187747B1
(en)
|
1997-09-08 |
2001-02-13 |
Panacea Biotech Limited |
Pharmaceutical composition comprising cyclosporin
|
US6008191A
(en)
*
|
1997-09-08 |
1999-12-28 |
Panacea Biotec Limited |
Pharmaceutical compositions containing cyclosporin
|
ES2256959T3
(es)
|
1997-10-08 |
2006-07-16 |
Isotechnika,Inc. |
Analogos de ciclosporina deuterados y no deuterados y su uso como agentes inmunomoduladores.
|
US20030220234A1
(en)
*
|
1998-11-02 |
2003-11-27 |
Selvaraj Naicker |
Deuterated cyclosporine analogs and their use as immunodulating agents
|
AU1509799A
(en)
*
|
1997-12-05 |
1999-06-28 |
Chong Kun Dang Corporation |
Pharmaceutical composition containing cyclosporin
|
US6063762A
(en)
*
|
1997-12-05 |
2000-05-16 |
Chong Kun Dang Corp. |
Cyclosporin-containing microemulsion preconcentrate composition
|
GB2380673B
(en)
*
|
1998-03-06 |
2003-05-28 |
Novartis Ag |
Emulsion preconcentrates containing cyclosporin or a macrolide
|
ID25908A
(id)
*
|
1998-03-06 |
2000-11-09 |
Novartis Ag |
Prakonsentrat-prakonsentrat emulsi yang mengandung siklosporin atau makrolida
|
JP4350898B2
(ja)
|
1998-07-01 |
2009-10-21 |
デビオファーム・ソシエテ・アノニム |
活性の特徴が改善された新規のシクロスポリン
|
EP0977180B1
(en)
*
|
1998-07-30 |
2005-02-09 |
STMicroelectronics S.r.l. |
Method for assembling an actuator device for a hard disc device, comprising a read/write transducer, a microactuator and a suspension and the actuator device thus obtained
|
RU2178293C2
(ru)
*
|
1998-08-18 |
2002-01-20 |
Панацея Биотек Лимитед |
Фармацевтическая композиция, содержащая циклоспорин, способ получения мягких желатиновых капсул
|
SE9804192D0
(sv)
*
|
1998-12-03 |
1998-12-03 |
Scotia Lipidteknik Ab |
New formulation
|
GB2344520A
(en)
*
|
1998-12-08 |
2000-06-14 |
Phares Pharm Res Nv |
Pharmaceutical carriers comprising lipids and polymers
|
NZ512287A
(en)
*
|
1998-12-11 |
2002-12-20 |
Pharmasolutions Inc |
Pharmaceutical compositions comprising a lipophilic drug in a propylene glycol ester of a higher fatty acid carrier, where 60% of the ester is a monoester
|
DK1154759T3
(da)
*
|
1998-12-30 |
2008-12-08 |
Dexcel Ltd |
Dispergerbart koncentrat til indgift af cyclosporin
|
GB9903547D0
(en)
*
|
1999-02-16 |
1999-04-07 |
Novartis Ag |
Organic compounds
|
US6294192B1
(en)
*
|
1999-02-26 |
2001-09-25 |
Lipocine, Inc. |
Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
|
US6267985B1
(en)
*
|
1999-06-30 |
2001-07-31 |
Lipocine Inc. |
Clear oil-containing pharmaceutical compositions
|
US6248363B1
(en)
*
|
1999-11-23 |
2001-06-19 |
Lipocine, Inc. |
Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
|
US6057289A
(en)
*
|
1999-04-30 |
2000-05-02 |
Pharmasolutions, Inc. |
Pharmaceutical composition comprising cyclosporin in association with a carrier in a self-emulsifying drug delivery system
|
GB9912476D0
(en)
|
1999-05-28 |
1999-07-28 |
Novartis Ag |
Organic compounds
|
DE19925001A1
(de)
*
|
1999-05-31 |
2000-12-07 |
Pharma Concepts Gmbh & Co Kg |
Flüssiges Konzentrat
|
US20030236236A1
(en)
*
|
1999-06-30 |
2003-12-25 |
Feng-Jing Chen |
Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
|
GB2355656B
(en)
*
|
1999-08-17 |
2004-04-07 |
Galena As |
Pharmaceutical compositions for oral and topical administration
|
JP2001122779A
(ja)
*
|
1999-10-26 |
2001-05-08 |
Toyo Capsule Kk |
経口投与用シクロスポリン含有ミクロエマルジョン濃縮液
|
AU1043201A
(en)
*
|
1999-11-02 |
2001-05-14 |
Cipla Limited |
Cyclosporin formulation
|
GB2362573A
(en)
*
|
2000-05-25 |
2001-11-28 |
Cipla Ltd |
Cyclosporin formulation
|
US7919113B2
(en)
*
|
1999-12-30 |
2011-04-05 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Dispersible concentrate lipospheres for delivery of active agents
|
US7732404B2
(en)
|
1999-12-30 |
2010-06-08 |
Dexcel Ltd |
Pro-nanodispersion for the delivery of cyclosporin
|
JP2003522578A
(ja)
|
2000-02-18 |
2003-07-29 |
アーゴス インク |
不均質組織における空間的に平均された励起−発光マップの生成
|
GB0008785D0
(en)
|
2000-04-10 |
2000-05-31 |
Novartis Ag |
Organic compounds
|
DE10029404B4
(de)
*
|
2000-06-15 |
2009-10-29 |
Jagotec Ag |
Arzneiformulierung enthaltend Ciclosporin und deren Verwendung
|
US6623765B1
(en)
*
|
2000-08-01 |
2003-09-23 |
University Of Florida, Research Foundation, Incorporated |
Microemulsion and micelle systems for solubilizing drugs
|
AU2545901A
(en)
*
|
2000-09-18 |
2002-03-26 |
Rpg Life Sciences Ltd |
Selfemulsifiable formulation having enhanced bioabsorption and immunosuppressionactivities
|
US6960563B2
(en)
*
|
2001-08-31 |
2005-11-01 |
Morton Grove Pharmaceuticals, Inc. |
Spontaneous emulsions containing cyclosporine
|
BR0213661A
(pt)
*
|
2001-10-19 |
2004-10-26 |
Isotechnika Inc |
Pré-concentrado de microemulsão e método para seu preparo, formulação farmacêutica e método para seu preparo, método para produzir imuno, supressão, método para aumentar os efeitos imuno supressores de isatx247, uso de formulação farmacêutica
|
RU2321593C9
(ru)
|
2001-10-19 |
2008-06-20 |
Изотехника Инк. |
Синтез аналогов циклоспорина
|
UA79766C2
(en)
|
2001-12-14 |
2007-07-25 |
Yahotech Ag |
Pharmaceutical formulation comprising cyclosporin and use thereof
|
US20050129718A1
(en)
*
|
2001-12-20 |
2005-06-16 |
Sherman Bernard C. |
Pharmaceutical compositions comprising a cyclosporin, a hydrophilic surfactant and a lipophilic surfactant
|
US7011846B2
(en)
*
|
2001-12-21 |
2006-03-14 |
Shire Laboratories, Inc. |
Oral capsule formulation with increased physical stability
|
KR100441167B1
(ko)
*
|
2001-12-27 |
2004-07-21 |
씨제이 주식회사 |
마이크로에멀젼 예비 농축액 조성물
|
US20040005339A1
(en)
*
|
2002-06-28 |
2004-01-08 |
Shojaei Amir H. |
Formulations of fenofibrate and/or fenofibrate derivatives with improved oral bioavailability
|
KR20040047056A
(ko)
*
|
2002-11-29 |
2004-06-05 |
한미약품 주식회사 |
비페닐디메틸디카복실레이트의 경구용 마이크로에멀젼조성물
|
US6979672B2
(en)
|
2002-12-20 |
2005-12-27 |
Polichem, S.A. |
Cyclosporin-based pharmaceutical compositions
|
KR100525234B1
(ko)
*
|
2003-02-19 |
2005-10-28 |
한국유나이티드제약 주식회사 |
사이클로스포린 함유 연질캅셀제 및 그 제조방법
|
US20050196370A1
(en)
*
|
2003-03-18 |
2005-09-08 |
Zhi-Jian Yu |
Stable ophthalmic oil-in-water emulsions with sodium hyaluronate for alleviating dry eye
|
US7181219B2
(en)
|
2003-05-22 |
2007-02-20 |
Lucent Technologies Inc. |
Wireless handover using anchor termination
|
GB0320638D0
(en)
|
2003-09-03 |
2003-10-01 |
Novartis Ag |
Organic compounds
|
US20050059583A1
(en)
|
2003-09-15 |
2005-03-17 |
Allergan, Inc. |
Methods of providing therapeutic effects using cyclosporin components
|
TW200517114A
(en)
|
2003-10-15 |
2005-06-01 |
Combinatorx Inc |
Methods and reagents for the treatment of immunoinflammatory disorders
|
US20060003002A1
(en)
*
|
2003-11-03 |
2006-01-05 |
Lipocine, Inc. |
Pharmaceutical compositions with synchronized solubilizer release
|
ZA200604253B
(en)
|
2003-11-21 |
2007-10-31 |
Combinatorx Inc |
Methods and reagents for the treatment of inflammatory disorders
|
PE20050596A1
(es)
*
|
2003-12-19 |
2005-10-18 |
Novartis Ag |
Microemulsion que comprende un inhibidor renina
|
IL159729A0
(en)
*
|
2004-01-06 |
2004-06-20 |
Doron I Friedman |
Non-aqueous composition for oral delivery of insoluble bioactive agents
|
US20050152968A1
(en)
*
|
2004-01-09 |
2005-07-14 |
Brophy Kristine M. |
Microemulsions for pharmaceutical compositions
|
JPWO2005089716A1
(ja)
*
|
2004-03-24 |
2008-01-31 |
武田薬品工業株式会社 |
高含量化製剤
|
CA2562388A1
(en)
*
|
2004-03-24 |
2005-09-29 |
Takeda Pharmaceutical Company Limited |
Emulsion-stabilized preparation
|
WO2006039558A2
(en)
*
|
2004-10-09 |
2006-04-13 |
Formurex, Inc. |
Ocular agent delivery systems
|
US7151085B2
(en)
*
|
2004-11-15 |
2006-12-19 |
Allergan, Inc. |
Therapeutic methods using cyclosporine components
|
US7135455B2
(en)
*
|
2004-11-15 |
2006-11-14 |
Allergan, Inc |
Methods for the therapeutic use of cyclosporine components
|
WO2006082588A2
(en)
*
|
2005-02-07 |
2006-08-10 |
Pharmalight Inc. |
Method and device for ophthalmic administration of active pharmaceutical ingredients
|
GB0504950D0
(en)
*
|
2005-03-10 |
2005-04-20 |
Novartis Ag |
Organic compositions
|
WO2006138507A1
(en)
|
2005-06-17 |
2006-12-28 |
Novartis Ag |
Use of sanglifehrin in hcv
|
US20070015693A1
(en)
*
|
2005-07-13 |
2007-01-18 |
Allergan, Inc. |
Cyclosporin compositions
|
US7288520B2
(en)
*
|
2005-07-13 |
2007-10-30 |
Allergan, Inc. |
Cyclosporin compositions
|
US20070015691A1
(en)
*
|
2005-07-13 |
2007-01-18 |
Allergan, Inc. |
Cyclosporin compositions
|
US7276476B2
(en)
*
|
2005-07-13 |
2007-10-02 |
Allergan, Inc. |
Cyclosporin compositions
|
US7202209B2
(en)
*
|
2005-07-13 |
2007-04-10 |
Allergan, Inc. |
Cyclosporin compositions
|
US7297679B2
(en)
*
|
2005-07-13 |
2007-11-20 |
Allergan, Inc. |
Cyclosporin compositions
|
US7501393B2
(en)
*
|
2005-07-27 |
2009-03-10 |
Allergan, Inc. |
Pharmaceutical compositions comprising cyclosporins
|
GT200600411A
(es)
*
|
2005-09-13 |
2007-05-21 |
Novartis Ag |
Combinaciones que comprenden un inhibidor del receptor del factor de crecimiento endotelial vascular
|
US7745400B2
(en)
*
|
2005-10-14 |
2010-06-29 |
Gregg Feinerman |
Prevention and treatment of ocular side effects with a cyclosporin
|
US9839667B2
(en)
|
2005-10-14 |
2017-12-12 |
Allergan, Inc. |
Prevention and treatment of ocular side effects with a cyclosporin
|
KR20080065704A
(ko)
|
2005-11-09 |
2008-07-14 |
콤비네이토릭스, 인코포레이티드 |
의학적 이상의 치료 방법들, 조성물들, 및 키트들
|
EP2001439A2
(en)
*
|
2006-03-07 |
2008-12-17 |
Novavax, Inc. |
Nanoemulsions of poorly soluble pharmaceutical active ingredients and methods of making the same
|
US10137083B2
(en)
|
2006-03-07 |
2018-11-27 |
SGN Nanopharma Inc |
Ophthalmic preparations
|
US11311477B2
(en)
|
2006-03-07 |
2022-04-26 |
Sgn Nanopharma Inc. |
Ophthalmic preparations
|
US20070221693A1
(en)
*
|
2006-03-24 |
2007-09-27 |
Moore Howard L |
Multi-purpose insulating and protective cover for containers
|
ITMI20060618A1
(it)
*
|
2006-03-31 |
2007-10-01 |
Enitecnologie Spa |
Procedimento per la preparazione di nanoemulsioni acqua ion olio e olio in acqua
|
ES2543840T3
(es)
|
2006-04-11 |
2015-08-24 |
Novartis Ag |
Inhibidores espirocíclicos del VHC/VIH y sus usos
|
AU2007339883A1
(en)
*
|
2006-12-28 |
2008-07-10 |
Limerick Biopharma, Inc. |
Methods and compositions for therapeutic treatment
|
JP5801534B2
(ja)
|
2007-01-04 |
2015-10-28 |
デビオファーム インターナショナル ソシエテ アノニム |
ウールリッヒ型先天筋ジストロフィーの処置のための、非免疫抑制性シクロスポリン
|
PT2079456E
(pt)
|
2007-04-04 |
2013-03-13 |
Sigmoid Pharma Ltd |
Composições farmacêuticas de ciclosporina
|
JP2010527285A
(ja)
|
2007-04-26 |
2010-08-12 |
シグモイド・ファーマ・リミテッド |
複数のミニカプセルの製造
|
EP2514406A1
(en)
*
|
2007-06-01 |
2012-10-24 |
Novo Nordisk A/S |
Spontaneously dispersible preconcentrates including a peptide drug in a solid or semisolid carrier
|
MX2010001141A
(es)
*
|
2007-07-31 |
2010-03-01 |
Limerick Biopharma Inc |
Analogos fosforiladosde pirona y metodos.
|
GB2451811A
(en)
|
2007-08-09 |
2009-02-18 |
Ems Sa |
Delivery composition for solubilising water-insoluble pharmaceutical active ingredients
|
CN101918019B
(zh)
|
2007-10-08 |
2014-11-26 |
奥里尼亚制药有限公司 |
包含钙调神经磷酸酶抑制剂或mTOR抑制剂的眼科组合物
|
BRPI0705564B8
(pt)
*
|
2007-10-10 |
2021-05-25 |
Embrapa Pesquisa Agropecuaria |
sistema do tipo cristal líquido contínuo contendo co-solvente portador de substâncias fracamente solúveis em água, seu processo de obtenção e seus usos
|
TW200932240A
(en)
*
|
2007-10-25 |
2009-08-01 |
Astellas Pharma Inc |
Pharmaceutical composition containing lipophilic substance which inhibits IL-2 production
|
BRPI0907805A2
(pt)
*
|
2008-02-28 |
2015-07-14 |
Novartis Ag |
Combinações para tratar dor associada à hiv
|
EP2257220B1
(en)
*
|
2008-03-13 |
2017-06-14 |
Liebel-Flarsheim Company LLC |
Multi-function, foot-activated controller for imaging system
|
CN102037008B
(zh)
|
2008-03-18 |
2016-08-31 |
诺沃-诺迪斯克有限公司 |
蛋白酶稳定化的、酰化胰岛素类似物
|
DE102008015299A1
(de)
|
2008-03-18 |
2009-09-24 |
Pkh Gmbh Halle |
Kolloidales Trägersystem
|
US11304960B2
(en)
|
2009-01-08 |
2022-04-19 |
Chandrashekar Giliyar |
Steroidal compositions
|
BRPI1006826A2
(pt)
*
|
2009-01-08 |
2017-08-15 |
Allergan Inc |
Composições para melhorar o crescimento de unhas
|
US8512690B2
(en)
|
2009-04-10 |
2013-08-20 |
Novartis Ag |
Derivatised proline containing peptide compounds as protease inhibitors
|
US20110182850A1
(en)
|
2009-04-10 |
2011-07-28 |
Trixi Brandl |
Organic compounds and their uses
|
JP5640079B2
(ja)
|
2009-05-18 |
2014-12-10 |
シグモイド・ファーマ・リミテッドSigmoid Pharma Limited |
油滴含有組成物
|
AU2010259184B2
(en)
*
|
2009-06-09 |
2015-08-13 |
Aurinia Pharmaceuticals Inc. |
Topical drug delivery systems for ophthalmic use
|
IN2012DN00781A
(ko)
|
2009-08-12 |
2015-06-26 |
Sigmoid Pharma Ltd |
|
EP2308468A1
(en)
*
|
2009-10-08 |
2011-04-13 |
Novaliq GmbH |
Novel pharmaceutical composition comprising a macrolide immunosuppressant drug
|
US8324239B2
(en)
|
2010-04-21 |
2012-12-04 |
Novartis Ag |
Furopyridine compounds and uses thereof
|
US20120077778A1
(en)
*
|
2010-09-29 |
2012-03-29 |
Andrea Bourdelais |
Ladder-Frame Polyether Conjugates
|
AU2011311880B2
(en)
|
2010-10-08 |
2014-07-24 |
Novartis Ag |
Vitamin E formulations of sulfamide NS3 inhibitors
|
GB201020032D0
(en)
|
2010-11-25 |
2011-01-12 |
Sigmoid Pharma Ltd |
Composition
|
US9358241B2
(en)
|
2010-11-30 |
2016-06-07 |
Lipocine Inc. |
High-strength testosterone undecanoate compositions
|
US20180153904A1
(en)
|
2010-11-30 |
2018-06-07 |
Lipocine Inc. |
High-strength testosterone undecanoate compositions
|
US9034858B2
(en)
|
2010-11-30 |
2015-05-19 |
Lipocine Inc. |
High-strength testosterone undecanoate compositions
|
US20120148675A1
(en)
|
2010-12-10 |
2012-06-14 |
Basawaraj Chickmath |
Testosterone undecanoate compositions
|
JO3337B1
(ar)
*
|
2010-12-13 |
2019-03-13 |
Debiopharm Sa |
تركيبات صيدلية تشمل أليسبوريفير
|
FR2971941B1
(fr)
|
2011-02-24 |
2013-08-02 |
Physica Pharma |
Compositions pharmaceutiques administrables par voie cutanee et destinees au traitement local de la dermatite atopique canine
|
KR101510764B1
(ko)
*
|
2011-10-10 |
2015-04-10 |
김용남 |
사이클로스포린 함유 안약 조성물 및 그 제조방법
|
EP2836508B1
(en)
|
2012-04-11 |
2016-06-29 |
Novo Nordisk A/S |
Insulin formulations
|
GB201212010D0
(en)
|
2012-07-05 |
2012-08-22 |
Sigmoid Pharma Ltd |
Formulations
|
US20140243300A1
(en)
*
|
2013-02-28 |
2014-08-28 |
Precision Dermatology, Inc. |
Controlling the Bioavailability of Active Ingredients in Topical Formulations
|
GB201319791D0
(en)
|
2013-11-08 |
2013-12-25 |
Sigmoid Pharma Ltd |
Formulations
|
US20170246187A1
(en)
|
2014-08-28 |
2017-08-31 |
Lipocine Inc. |
(17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
|
WO2016033556A1
(en)
|
2014-08-28 |
2016-03-03 |
Lipocine Inc. |
BIOAVAILABLE SOLID STATE (17-β)-HYDROXY-4-ANDROSTEN-3-ONE ESTERS
|
KR20170102223A
(ko)
|
2014-11-07 |
2017-09-08 |
시그모이드 파마 리미티드 |
사이클로스포린을 포함하는 조성물
|
EP3187172A1
(en)
*
|
2016-01-04 |
2017-07-05 |
Spherium Biomed S.L. |
Cyclosporine a topical compositions
|
WO2018098501A1
(en)
|
2016-11-28 |
2018-05-31 |
Lipocine Inc. |
Oral testosterone undecanoate therapy
|
US20180169190A1
(en)
|
2016-12-16 |
2018-06-21 |
Novo Nordisk A/S |
Insulin containing pharmaceutical compositions
|
US20190224275A1
(en)
|
2017-05-12 |
2019-07-25 |
Aurinia Pharmaceuticals Inc. |
Protocol for treatment of lupus nephritis
|
WO2019002362A1
(en)
*
|
2017-06-28 |
2019-01-03 |
Spherium Biomed, S.L. |
TOPICAL COMPOSITIONS OF CYCLOSPORIN A
|
KR102146704B1
(ko)
|
2018-04-13 |
2020-08-21 |
가천대학교 산학협력단 |
사이클로스포린 A (CsA) 경피 및 피내 약물전달용 마이크로구조체
|
US20200163876A1
(en)
*
|
2018-11-26 |
2020-05-28 |
Hepion Pharmaceuticals, Inc. |
Pharmaceutical formulations of cyclosporine analogs
|